French drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock reports.
01:02
00:47
00:28
02:19
00:52
00:33
01:15
00:33
01:04
02:26
01:01
01:05
00:25
00:52
01:28
02:22
02:51
03:03
02:30
01:59
02:22
00:47
01:22
01:08
01:01
02:59
01:49
00:49
02:23
00:50
02:26
01:53
00:45
01:09
00:55
01:27
00:49
00:45
01:03
01:34
00:47
00:28
00:52
00:33
01:05
00:25
01:59
01:34
00:33
00:40
00:28
00:26
01:23
00:43
01:24
01:21
00:30
00:42
01:15
01:22
01:02
01:28
01:57
01:03
02:00
03:34
01:30
00:51
02:02
00:51
02:07
02:05
01:36
01:23
02:26
01:11
00:28
01:38
01:00
01:23
01:18
01:09
01:23
01:26
01:35
01:07
02:52
05:07
01:11
01:42
01:55
01:29
00:59
00:49
00:57
01:41
02:09
01:36
00:48
01:00